EUVIMEDEUVIMED entdecken
Crossref

De Novo 3-(Phenylcarbamoyl) Benzoate Analogues: Efficacy against Multidrug-Resistant S. aureus and Elucidation of the Biodistribution Profile

Himanshu Sonker, Kajal Chaudhary, Bhumika Agrahari, Sayari Dewan, Ankit iD, Ayushi Chaudhary, Ashwini Kumar, Nikhil Swain, Ritika Gautam Singh iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Himanshu Sonker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, IIT, Kanpur 208016, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Benzoates, Drug Resistance, Multiple, Bacterial, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Council??of??Scientific and Industrial Research, India, Department of Science and Technology, Ministry of Science and Technology, Ministry of Human Resource Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents the first design, synthesis, and characterization of a novel library of carboxylate analogues of 3-(phenylcarbamoyl) benzoate (L1-L17) as potent antimicrobial agents targeting Staphylococcus aureus infections. The lead compounds L8, L13, L14, and L15 demonstrated significant activity against methicillin- and vancomycin-resistant S. aureus (MRSA and VRSA, respectively) with MIC values of 2-8 μg/mL. Mechanistic investigations using scanning electron microscopy (SEM) and atomic force microscopy (AFM) revealed bacterial membrane disruption as the primary mode of action. Further in vitro, in silico, and in vivo analyses identified L13 and L15 as the most promising candidates. A translational study using a BALB/c mouse skin abscess model confirmed their therapeutic potential, supported by biodistribution profiling via LC/Q-TOF mass spectrometry. These findings mark a significant step toward developing novel antibiotics against S. aureus, particularly for hospital-acquired infections, offering a promising avenue in the fight against antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBenzoatesDrug Resistance, Multiple, BacterialMethicillin-Resistant Staphylococcus aureusStaphylococcus aureusAnimalsFemaleMiceMice, Inbred BALB CMicrobial Sensitivity TestsStaphylococcal InfectionsStructure-Activity RelationshipTissue DistributionLigands

Substanzen

Anti-Bacterial AgentsBenzoatesLigands

Autor:innen und Institutionen

  • Department of Chemistry, IIT, Kanpur 208016, Uttar Pradesh, India.

ORCID-Profile: Ankit, Ritika Gautam Singh

Förderung

  • Council??of??Scientific and Industrial Research, India
  • Department of Science and Technology, Ministry of Science and Technology
  • Ministry of Human Resource Development
  • CSIR ASPIRE

Zitieren

APA

Sonker, H., Chaudhary, K., Agrahari, B., Dewan, S., Ankit, Chaudhary, A., Kumar, A., Swain, N., & Singh, R. G. (2025). De Novo 3-(Phenylcarbamoyl) Benzoate Analogues: Efficacy against Multidrug-Resistant S. aureus and Elucidation of the Biodistribution Profile. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00515

Vancouver

Sonker H, Chaudhary K, Agrahari B, Dewan S, Ankit, Chaudhary A, et al. De Novo 3-(Phenylcarbamoyl) Benzoate Analogues: Efficacy against Multidrug-Resistant S. aureus and Elucidation of the Biodistribution Profile. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00515

BibTeX
@article{Sonker2025,
  author = {Sonker, Himanshu and Chaudhary, Kajal and Agrahari, Bhumika and Dewan, Sayari and Ankit and Chaudhary, Ayushi and Kumar, Ashwini and Swain, Nikhil and Singh, Ritika Gautam},
  title = {De Novo 3-(Phenylcarbamoyl) Benzoate Analogues: Efficacy against Multidrug-Resistant S. aureus and Elucidation of the Biodistribution Profile},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00515}
}
Kostenlos starten →